Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease

J Neurol. 2011 Apr;258(4):704-5. doi: 10.1007/s00415-010-5816-9. Epub 2010 Nov 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4 / genetics
  • Confidence Intervals
  • Cyclin-Dependent Kinase Inhibitor p15 / genetics*
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics*
  • DNA Mutational Analysis
  • Diagnostic Imaging / methods
  • Female
  • Gene Frequency
  • Genetic Variation / genetics*
  • Genotype
  • Humans
  • Linkage Disequilibrium
  • Male
  • Odds Ratio
  • Psychiatric Status Rating Scales

Substances

  • Apolipoprotein E4
  • CDKN2B protein, human
  • Cyclin-Dependent Kinase Inhibitor p15
  • Cyclin-Dependent Kinase Inhibitor p16